Healthcare company Abbott has agreed to team up with the American Diabetes Association (ADA) to better understand how diabetes technology can help diabetics make informed decisions on what they eat and their lifestyle activities.
With a 20-year-old relationship between Abbott and the ADA, this latest partnership will provide the ADA with $2.65m over the next three years.
The funds will be used in various ways, including connecting healthcare professionals and opinion leaders to assess clinical evidence on continuous glucose monitoring (CGM) systems for personalised nutrition.
